HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (OTC:IPXL) ("IMPAX" or the "Company") reported that it has completed its discussions with the Office of the Chief Accountant (“OCA”) of the Securities and Exchange Commission (“SEC”) concerning the manner in which the Company will account for transactions under its Strategic Alliance Agreement with an affiliate of Teva Pharmaceutical Industries, Ltd. The Company is proceeding with the completion of the audits of its 2004, 2005 and 2006 financial statements and, based on information currently available, estimates that it will be able to bring its SEC filings current within eight to twelve weeks.
